Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 11, 2026
Why Is OppFi Inc (OPFI) Stock Down -20.07% Today?

Why Is OppFi Inc (OPFI) Stock Down -20.07% Today?

Key Takeaways

  • OPFI shares plunged 20.07% to $7.01, extending a brutal two-day selloff following the company's Q2 2026 earnings release after Monday's close.
  • Earnings and revenue both missed consensus estimates, with adjusted EPS of $0.33 falling well short of the $0.44–$0.46 Wall Street expected.
  • Full-year 2026 guidance was slashed across all key metrics, with revenue now seen at $600–$625 million, down from $650–$675 million, and adjusted EPS cut to $1.34–$1.51 from $1.76–$1.84.
  • Multiple analyst downgrades and price-target cuts intensified selling pressure, with Citizens lowering its target from $15 to $11 and Stephens dropping to $9.50 from $11.
  • Rising charge-offs and falling originations signaled deteriorating credit trends, compounding concerns about near-term execution risk from delayed product launches.
  • Traders are now watching whether the stock can stabilize near its 52-week low of $7.36 or if further downside awaits as the market digests the magnitude of the guidance revision.

Opening Summary

OPFI, the Chicago-based fintech lender operating the OppLoans digital platform for near-prime consumers, is experiencing one of its sharpest single-day declines on record. Shares of OppFi Inc (OPFI) cratered 20.07% to trade at $7.01 on Tuesday, building on a 6.7% drop during Monday's regular session. The stock closed Monday at $8.77 after the company reported second-quarter results that missed Wall Street expectations on both the top and bottom lines, followed by a deeply disappointing full-year guidance revision. Tuesday's session reflects the market's first full trading day to absorb the magnitude of the miss and the broader implications for OppFi's growth trajectory.

Q2 Earnings Miss and Guidance Slash

The primary catalyst behind OPFI's collapse is the company's Q2 2026 earnings report, released after the market closed on Monday. While OppFi posted record second-quarter revenue of $145 million — a 1.9% increase year-over-year — the figure fell roughly 7% short of the $155.9 million consensus estimate. More concerning to investors, adjusted earnings per share came in at $0.33, missing the $0.44–$0.46 analyst forecast by a wide margin.

The bottom-line weakness was driven by a combination of factors: originations declined approximately 9% year-over-year to $212 million as the company tightened underwriting standards in less attractive risk segments, while net charge-offs surged to roughly 40% of revenue, up from 32% in the prior-year quarter. Adjusted net income tumbled 27% to approximately $29 million from $40 million a year earlier.

Even more disruptive to the stock's valuation was the full-year 2026 guidance revision. Management cut its revenue outlook to $600–$625 million from $650–$675 million, reduced adjusted net income guidance to $115–$130 million from $153–$160 million, and slashed adjusted EPS guidance to $1.34–$1.51 from $1.76–$1.84. CEO Todd Schwartz attributed the downgrade primarily to delayed product launches — including a roughly two-month pushback of the company's new line-of-credit product and a slower-than-expected migration to the LOLA modular technology platform — rather than fundamental deterioration in the credit environment.

Analyst Downgrades Compound Selling Pressure

The market's negative reaction was amplified on Tuesday by a wave of analyst price-target reductions. Citizens lowered its target on OPFI to $11 from $15 while maintaining a Market Outperform rating, citing weaker-than-expected origination volumes and intensifying competitive pressure. Stephens cut its target to $9.50 from $11, keeping an Equal Weight rating, while noting the Q2 miss and the magnitude of the guidance revision. These adjustments reflect a growing consensus on Wall Street that near-term execution risk has risen materially as OppFi transitions toward a multi-product, bank-centered fintech platform.

Credit Trends and Origination Headwinds

Underneath the headline numbers, several concerning credit trends emerged. Net charge-offs as a percentage of average receivables climbed to approximately 52%, up from 43% in the prior-year period. Management noted that slower portfolio growth inflated these metrics — had originations been growing at 9–10%, the charge-off ratio would be roughly 500 basis points lower — but the direction of travel remains troubling. Originations contracted 9% year-over-year, reflecting both deliberate tightening in riskier segments and a consumer environment where borrowers are increasingly opting for longer-duration, lower-monthly-payment products that carry higher total costs and elevated credit risk over time.

Market Context and Trading Activity

Trading volume in OPFI surged well above normal levels, with Monday's regular session seeing over 900,000 shares change hands compared to an average daily volume of roughly 584,000 — and Tuesday's activity poised to eclipse even that elevated figure. The stock's decline was company-specific rather than sector-driven, as broader financial and fintech indices did not exhibit comparable stress on Tuesday. The S&P 500 was essentially flat in Monday's session, and Asian markets were mixed on Tuesday. OPFI has now decisively breached its 50-day moving average of approximately $9.09 and its 200-day moving average near $8.89, trading perilously close to its 52-week low of $7.36 — a level that, if broken, could trigger additional technical selling.

What Comes Next for OPFI

Looking ahead, OPFI faces a critical second-half 2026 as management works to execute on several strategic initiatives that were pushed back during the quarter. The new line-of-credit product is now slated for a September launch in three new geographies, and its reception will be closely scrutinized as a test of the company's multi-product strategy. The pending BNC National Bank acquisition — for which regulatory applications have been submitted with a target close in Q4 2026 — represents a potentially transformative catalyst, though the timeline remains subject to regulatory approval and is largely outside the company's control. On the positive side, management reaffirmed its long-term targets of approximately $3.00 in adjusted EPS by 2028 and $500 million in adjusted net income within five years, and the company began repurchasing shares under a $40 million authorization, signaling confidence in long-term earnings power. Still, with consumer credit trends remaining variable and product-launch execution risk elevated, the path to recovery is unlikely to be linear.

Trending AI Robots

For investors seeking to navigate volatile markets with data-driven tools, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to evolving market conditions. Tickeron's ecosystem includes hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market dynamics are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore automated approaches aligned with their investment objectives. Explore the Trending AI Robots page to discover which AI strategies are outperforming right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: OPFI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


OPFI's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for OPFI turned positive on August 03, 2026. Looking at past instances where OPFI's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on OPFI as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OPFI advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OPFI moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where OPFI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPFI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OPFI broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OPFI entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OPFI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.901) is normal, around the industry mean (4.475). P/E Ratio (4.320) is within average values for comparable stocks, (16.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.068) among similar stocks. P/S Ratio (0.607) is also within normal values, averaging (6.114).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPFI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

Notable companies

The most notable companies in this group are VISA (NYSE:V), Mastercard (NYSE:MA), American Express Company (NYSE:AXP), Capital One Financial (NYSE:COF), PayPal Holdings (NASDAQ:PYPL), Synchrony Financial (NYSE:SYF), SLM Corp (NASDAQ:SLM), Bread Financial Holdings (NYSE:BFH), LexinFintech Holdings Ltd (NASDAQ:LX).

Industry description

A savings bank primary function is to take deposits and paying interest on those deposits. Originating in Europe during the 18th century, these banks were generally introduced to incentivize people of all stripes to save money and park them with banks. By the 1990s, the internet ushered in online savings banks that allowed savers to deposit/transact with banks digitally, without requiring to visit a branch office. Savings banks have potentially encouraged lower-income population to save and have access to a financial institution to earn interest on their money. New York Community Bancorp, Inc, Webster Financial Corporation, Washington Federal, Inc. are examples of savings banks.

Market Cap

The average market capitalization across the Savings Banks Industry is 34.19B. The market cap for tickers in the group ranges from 1.59M to 668.96B. V holds the highest valuation in this group at 668.96B. The lowest valued company is DXF at 1.59M.

High and low price notable news

The average weekly price growth across all stocks in the Savings Banks Industry was 2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 7%. VRM experienced the highest price growth at 43%, while SEZL experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Savings Banks Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 63
Price Growth Rating: 53
SMR Rating: 49
Profit Risk Rating: 75
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
OPFI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry SavingsBanks

Profile
Details
Industry
N/A
Address
130 East Randolph Street
Phone
+1 312 212-8079
Employees
445
Web
https://www.oppfi.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.